Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Jul;70(1):21–28. doi: 10.1038/bjc.1994.244

A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin.

S Iinuma 1, S S Farshi 1, B Ortel 1, T Hasan 1
PMCID: PMC2033301  PMID: 8018536

Abstract

5-Aminolaevulinic acid (ALA)-induced porphyrin biosynthesis and phototoxicity in vitro was investigated in five malignant and two normal cell lines. Intracellular protoporphyrin IX (PpIX) content was quantified by extraction and fluorescence spectroscopy. Cellular PpIX content did not always correlate with cell proliferation rate as measured by the doubling times of cell lines. Cellular efflux of PpIX was also investigated. In a bladder carcinoma cell line, the observed rapid efflux was not blocked by verapamil, an inhibitor of the P-glycoprotein efflux pump. These data support the view that cellular PpIX accumulation is a dynamic process that is determined by both the efflux of PpIX from the cells and enzyme activities in the haem biosynthesis pathway. Desferrioxamine (desferal), a modulator of PpIX biosynthesis, enhanced ALA-induced cellular PpIX content significantly in all carcinoma cell lines but not in non-malignant cell lines. The enhanced PpIX cellular accumulation is attributed to inhibition of ferrochelatase activity, the enzyme responsible for the conversion of PpIX to haem. PpIX-mediated cellular photodestruction following irradiation with an argon ion laser at 514.5 nm was determined by the 'MTT assay'. There appeared to be a 'threshold' effect of cellular PpIX content; cells that synthesised less than 140 ng/mg-1 protein exhibited very little phototoxic damage, while cell lines having greater than 140 ng PpIX/mg-1 protein [corrected] exhibited a consistent phototoxic response. Among the cell lines which did undergo phototoxic damage, there was not a strict correlation between PpIX cellular content and ALA-induced phototoxicity. Desferal enhanced the PpIX content and phototoxic effect in the responsive cells. Fluorescence microscopy of the ALA-treated cells revealed marked accumulation of PpIX in mitochondria (rhodamine 123 co-staining). That the primary site of phototoxic damage is also the mitochondria was confirmed by electron micrographs of cells photosensitised with ALA-induced PpIX, which showed swelling of mitochondria within minutes after irradiation while other suborganelles appeared to be unaffected. The repair or further destruction of the mitochondria was fluence and cell-type dependent. The data from this study suggest that the basis of increased ALA-induced PpIX accumulation in tumours is a combination of various aspects of the metabolic process and pharmacokinetics and that the efficacy of photodestruction of malignancy will be determined not only by the rate of PpIX synthesis but also by specific cellular and tissue characteristics.

Full text

PDF
21

Images in this article

25Figure 4
on p.25
25Figure 5
on p.25
26Figure 7
on p.26

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellnier D. A., Prout G. R., Jr, Lin C. W. Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo. J Natl Cancer Inst. 1985 Mar;74(3):617–625. [PubMed] [Google Scholar]
  2. Benson R. C., Jr Treatment of bladder cancer with hematoporphyrin derivatives and laser light. Urology. 1988 Feb;31(2 Suppl):13–17. [PubMed] [Google Scholar]
  3. Bonkovsky H. L., Healey J. F., Sinclair P. R., Sinclair J. F. Conversion of 5-aminolaevulinate into haem by homogenates of human liver. Comparison with rat and chick-embryo liver homogenates. Biochem J. 1985 May 1;227(3):893–901. doi: 10.1042/bj2270893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  5. Divaris D. X., Kennedy J. C., Pottier R. H. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol. 1990 Apr;136(4):891–897. [PMC free article] [PubMed] [Google Scholar]
  6. Dougherty T. J. Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol. 1987 Jun;45(6):879–889. doi: 10.1111/j.1751-1097.1987.tb07898.x. [DOI] [PubMed] [Google Scholar]
  7. Fukuda H., Batlle A. M., Riley P. A. Kinetics of porphyrin accumulation in cultured epithelial cells exposed to ALA. Int J Biochem. 1993 Oct;25(10):1407–1410. doi: 10.1016/0020-711x(93)90689-c. [DOI] [PubMed] [Google Scholar]
  8. Goff B. A., Bachor R., Kollias N., Hasan T. Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs. J Photochem Photobiol B. 1992 Aug 31;15(3):239–251. doi: 10.1016/1011-1344(92)85128-h. [DOI] [PubMed] [Google Scholar]
  9. Goff B. A., Bamberg M., Hasan T. Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res. 1991 Sep 15;51(18):4762–4767. [PubMed] [Google Scholar]
  10. Gomer C. J. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem Photobiol. 1991 Dec;54(6):1093–1107. doi: 10.1111/j.1751-1097.1991.tb02133.x. [DOI] [PubMed] [Google Scholar]
  11. Granick S., Sinclair P., Sassa S., Grieninger G. Effects by heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition. J Biol Chem. 1975 Dec 25;250(24):9215–9225. [PubMed] [Google Scholar]
  12. Henderson B. W., Dougherty T. J. How does photodynamic therapy work? Photochem Photobiol. 1992 Jan;55(1):145–157. doi: 10.1111/j.1751-1097.1992.tb04222.x. [DOI] [PubMed] [Google Scholar]
  13. Kennedy J. C., Pottier R. H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992 Jul 30;14(4):275–292. doi: 10.1016/1011-1344(92)85108-7. [DOI] [PubMed] [Google Scholar]
  14. Kennedy J. C., Pottier R. H., Pross D. C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990 Jun;6(1-2):143–148. doi: 10.1016/1011-1344(90)85083-9. [DOI] [PubMed] [Google Scholar]
  15. Ling V. Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs. Cancer. 1992 May 15;69(10):2603–2609. doi: 10.1002/1097-0142(19920515)69:10<2603::aid-cncr2820691034>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  16. Loh C. S., Bedwell J., MacRobert A. J., Krasner N., Phillips D., Bown S. G. Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br J Cancer. 1992 Sep;66(3):452–462. doi: 10.1038/bjc.1992.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Loh C. S., MacRobert A. J., Bedwell J., Regula J., Krasner N., Bown S. G. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer. 1993 Jul;68(1):41–51. doi: 10.1038/bjc.1993.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Loh C. S., Vernon D., MacRobert A. J., Bedwell J., Bown S. G., Brown S. B. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol B. 1993 Sep;20(1):47–54. doi: 10.1016/1011-1344(93)80130-2. [DOI] [PubMed] [Google Scholar]
  19. Malik Z., Ehrenberg B., Faraggi A. Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins. J Photochem Photobiol B. 1989 Nov;4(2):195–205. doi: 10.1016/1011-1344(89)80005-3. [DOI] [PubMed] [Google Scholar]
  20. Malik Z., Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer. 1987 Nov;56(5):589–595. doi: 10.1038/bjc.1987.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  22. Pandey R. K., Bellnier D. A., Smith K. M., Dougherty T. J. Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochem Photobiol. 1991 Jan;53(1):65–72. doi: 10.1111/j.1751-1097.1991.tb08468.x. [DOI] [PubMed] [Google Scholar]
  23. Pottier R. H., Chow Y. F., LaPlante J. P., Truscott T. G., Kennedy J. C., Beiner L. A. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol. 1986 Nov;44(5):679–687. doi: 10.1111/j.1751-1097.1986.tb04726.x. [DOI] [PubMed] [Google Scholar]
  24. Rebeiz N., Rebeiz C. C., Arkins S., Kelley K. W., Rebeiz C. A. Photodestruction of tumor cells by induction of endogenous accumulation of protoporphyrin IX: enhancement by 1,10-phenanthroline. Photochem Photobiol. 1992 Mar;55(3):431–435. doi: 10.1111/j.1751-1097.1992.tb04258.x. [DOI] [PubMed] [Google Scholar]
  25. Smith A. Mechanisms of toxicity of photoactivated artificial porphyrins. Role of porphyrin-protein interactions. Ann N Y Acad Sci. 1987;514:309–322. doi: 10.1111/j.1749-6632.1987.tb48786.x. [DOI] [PubMed] [Google Scholar]
  26. Van Hillegersberg R., Van den Berg J. W., Kort W. J., Terpstra O. T., Wilson J. H. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology. 1992 Aug;103(2):647–651. doi: 10.1016/0016-5085(92)90860-2. [DOI] [PubMed] [Google Scholar]
  27. West C. M., West D. C., Kumar S., Moore J. V. A comparison of the sensitivity to photodynamic treatment of endothelial and tumour cells in different proliferative states. Int J Radiat Biol. 1990 Jul;58(1):145–156. doi: 10.1080/09553009014551501. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES